Sudden Sensorineural Hearing Loss in Wonju Severance Christian Hospital

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-100
SponsorWonju Severance Christian Hospital

About this trial

This study is to build a cohort of sudden sensorineural hearing loss (SSNHL) patients. When the patient visited the Department of otolaryngology clinic for hearing loss, we can diagnose the SSNHL following the result of pure tone audiometry and the history of the patient. The cohort is a system that tracks the hearing recovery status, timing, and degree of recovery of patients who received cocktail therapy with or without high-dose steroids, vasodilators, antiviral agents, and intratympanic steroid injections, satellite ganglion block, and hyperbaric oxygen therapy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients over 20 years of age

A patient who visited Wonju Severance Christian Hospital, Department of Otolaryngology and was diagnosed with sudden hearing loss as it was confirmed that hearing loss of 30dBHL or more occurred within 3 days at three consecutive frequencies in a pure tone audiometry test.

Those who have fully explained the purpose and content of the study and voluntarily agreed to the written consent

Disqualifiers

If the patients do not want to or do not fill out the consent form

If treatment is started for sudden hearing loss, but the possibility of other inner ear diseases including Meniere's disease is suspected due to repeated hearing loss, repeated recovery, dizziness, tinnitus, etc.

Other cases where it is judged difficult to carry out the clinical trial due to the judgment of the person in charge of the above clinical trial

Trial population

Among the adults over 20yrs of age, diagnosed sudden sensorineural hearing loss at Wonju Severance Christian Hospital, Department of otolaryngology.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

1,000 Participants
are grouped into 1 trial group
Group A: SSNHL treated with WSCH protocol

Trial outcomes

Primary outcomes

1

Hearing outcome 1 week - PTA

Hearing change status near 1 weak after treatment start measured by pure tone audiometry1

Time frame
1 week PTA
2

Hearing outcome 3 weeks - PTA

Hearing change status near 3 weaks after treatment start measured by pure tone audiometry

Time frame
3 weeks PTA
3

Hearing outcome 2 months - PTA

Hearing change status near 3 weaks after treatment start measured by pure tone audiometry

Time frame
2 month PTA
4

Hearing outcome 3 months - PTA

Hearing change status near 3 months after treatment start measured by pure tone audiometry

Time frame
3 month PTA

Secondary outcomes

1

Electrolytes and chemistries after high dose steroid therapy

The results of blood tests of electrolytes and chemistries at 5 days after treatment start. (Na, K, Cl, CO2, BUN, Cr, Glucose, Amylase, Total protein, Albumin, AST, ALT, ALP, r-GT, Total Bilirubin)

Time frame
5 days electrolytes and chemistries

Other outcomes

1

Internal Acoustic canal MRI

The baseline studies of internal acoustic canal MRI results of SSNHL patients.

Time frame
MRI

Sponsors and contacts

Click on the lead sponsor to view all of their trials.